Financial Analysis: Intelligent Bio Solutions (NASDAQ:INBS) vs. Eurofins Scient (OTCMKTS:ERFSF)

Eurofins Scient (OTCMKTS:ERFSF) and Intelligent Bio Solutions (NASDAQ:INBS) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk.

Valuation & Earnings

This table compares Eurofins Scient and Intelligent Bio Solutions”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Eurofins Scient	$8.25 billion	1.77	$537.29 million	N/A	N/A
Intelligent Bio Solutions	$3.05 million	1.41	-$10.57 million	($12.22)	-0.15

Eurofins Scient has higher revenue and earnings than Intelligent Bio Solutions.

Profitability

This table compares Eurofins Scient and Intelligent Bio Solutions’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Eurofins Scient	N/A	N/A	N/A
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%

Institutional and Insider Ownership

33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 1.3% of Intelligent Bio Solutions shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a summary of current ratings for Eurofins Scient and Intelligent Bio Solutions, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Eurofins Scient	0	2	1	0	2.33
Intelligent Bio Solutions	1	1	0	0	1.50

Risk & Volatility

Eurofins Scient has a beta of 0.59, suggesting that its stock price is 41% less volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.18, suggesting that its stock price is 318% more volatile than the S&P 500.

Summary

Eurofins Scient beats Intelligent Bio Solutions on 8 of the 11 factors compared between the two stocks.

About Eurofins Scient

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.